Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

The Myositis Activities Profile -- initial validation for assessment of polymyositis/dermatomyositis in the USA.

Alexanderson H, Reed AM, Ytterberg SR.

J Rheumatol. 2012 Nov;39(11):2134-41. doi: 10.3899/jrheum.120504. Epub 2012 Sep 1.

PMID:
22942260
3.

Functional index-2: Validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis.

Alexanderson H, Broman L, Tollbäck A, Josefson A, Lundberg IE, Stenström CH.

Arthritis Rheum. 2006 Feb 15;55(1):114-22.

4.

Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis.

Alexanderson H, Dastmalchi M, Esbjörnsson-Liljedahl M, Opava CH, Lundberg IE.

Arthritis Rheum. 2007 Jun 15;57(5):768-77.

6.

Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies.

Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, Feldman BM, Wright SJ, Lindsley CB, Pachman LM, Villalba ML, Lovell DJ, Bowyer SL, Plotz PH, Miller FW, Hicks JE.

Arthritis Care Res (Hoboken). 2010 Apr;62(4):465-72. doi: 10.1002/acr.20035.

7.

Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis.

Alemo Munters L, van Vollenhoven RF, Alexanderson H.

ISRN Rheumatol. 2011;2011:463124. doi: 10.5402/2011/463124. Epub 2011 Apr 12.

8.

Development and validation of a short form of the valued life activities disability questionnaire for rheumatoid arthritis.

Katz PP, Radvanski DC, Allen D, Buyske S, Schiff S, Nadkarni A, Rosenblatt L, Maclean R, Hassett AL.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1664-71. doi: 10.1002/acr.20617.

9.

Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Huber AM, Hicks JE, Lachenbruch PA, Perez MD, Zemel LS, Rennebohm RM, Wallace CA, Lindsley CB, Passo MH, Ballinger SH, Bowyer SL, Reed AM, White PH, Katona IM, Miller FW, Rider LG, Feldman BM; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

J Rheumatol. 2001 May;28(5):1106-11.

PMID:
11361197
10.

Validation of an Italian version of the functional index for hand osteoarthritis (FIHOA).

Gandini F, Giannitti C, Fattore G, Giordano N, Galeazzi M, Fioravanti A.

Mod Rheumatol. 2012 Sep;22(5):758-65. doi: 10.1007/s10165-011-0579-4. Epub 2012 Jan 15.

PMID:
22245976
11.

[Myositis disease activity tool in Chinese patients with polymyositis/dermatomyositis].

Shu XM, Ma L, Lu X, Xie Y, Wang GC.

Zhonghua Yi Xue Za Zhi. 2011 May 24;91(19):1328-30. Chinese.

PMID:
21756759
12.

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality.

Sultan SM, Ioannou Y, Moss K, Isenberg DA.

Rheumatology (Oxford). 2002 Jan;41(1):22-6.

13.

Disease-specific quality indicators, outcome measures and guidelines in polymyositis and dermatomyositis.

Alexanderson H, Lundberg IE.

Clin Exp Rheumatol. 2007 Nov-Dec;25(6 Suppl 47):153-8.

PMID:
18021522
14.

Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients.

Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P, Loustaud-Ratti V, Bouyssou-Gauthier ML, Boulinguez S, Bédane C, Jauberteau MO, Vidal E, Bonnetblanc JM.

Arch Dermatol. 2002 Jul;138(7):885-90.

PMID:
12071815
15.

Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension followup.

Alemo Munters L, Dastmalchi M, Andgren V, Emilson C, Bergegård J, Regardt M, Johansson A, Orefelt Tholander I, Hanna B, Lidén M, Esbjörnsson M, Alexanderson H.

Arthritis Care Res (Hoboken). 2013 Dec;65(12):1959-68. doi: 10.1002/acr.22068.

16.

Quality of life in adults with juvenile-onset dermatomyositis: a case-control study.

Tollisen A, Sanner H, Flatø B, Wahl AK.

Arthritis Care Res (Hoboken). 2012 Jul;64(7):1020-7. doi: 10.1002/acr.21637.

17.

Role of bone scan in the assessment of polymyositis/dermatomyositis.

An YS, Suh CH, Jung JY, Kim HA.

Clin Rheumatol. 2015 Apr;34(4):699-706. doi: 10.1007/s10067-014-2837-2. Epub 2014 Dec 12.

PMID:
25501462
18.

Polymyositis: an overdiagnosed entity.

van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, Dinant HJ, Linssen WH, Wokke JH, de Visser M.

Neurology. 2003 Aug 12;61(3):316-21.

PMID:
12913190
19.

Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index.

Rider LG, Lachenbruch PA, Monroe JB, Ravelli A, Cabalar I, Feldman BM, Villalba ML, Myones BL, Pachman LM, Rennebohm RM, Reed AM, Miller FW; IMACS Group.

Arthritis Rheum. 2009 Nov;60(11):3425-35. doi: 10.1002/art.24904.

20.

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.

Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM; Scleroderma Clinical Trials Consortium.

Arthritis Rheum. 2002 Sep;46(9):2410-20.

Items per page

Supplemental Content

Write to the Help Desk